Biomedtech Portfolio

Caranx Medical

Autonomous robot improving efficiency and safety in Transcatheter Aortic Valve Replacement (TAVI) procedures

Caranx's Website

Caranx Medical, founded by Truffle Capital in 2019, is a MedTech company focused on designing intelligent, autonomous robots that enhance patient outcomes through AI and robotic-assisted interventions. Their initial applications target aortic valve replacement (TAVI).

LATEST NEWS

April 16, 2024

Caranx Medical, announced the successful world first robotic assisted heart valve (aortic valve) implantation in an animal

March 28, 2022

Caranx Medical announces the signature of an exlusive Worldwide license with Stanford and UC Santa Barbara universities and a €2M financing from Bpifrance

OTHER COMPANIES

BariaTek

Minimally invasive, atraumatic, reversible and endoscopically delivered medical device to treat o...

Artedrone

Autonomous robotic solution to increase the accessibility of mechanical thrombectomy during acute...

Carbios

Biotechnology powering plastic and textile circularity

Affluent Medical

Minimally invasive, biomimetic and adjustable solutions for mitral regurgitation and urinary inco...

Abivax

Regulating the immune response through microRNA

Holistick Medical

Patent Foramen Ovale (PFO) treatment through next generation medical devices

Seacure

Seacure leverages natural processes to fight against coastal erosion and protect marine structures

Theraclion

Medical devices levaraging Focused Ultrasounds to treat varicose veins, Fibroadenoma and Thyroid...

Theradiag

In-vitro diagnostics for autoimmune diseases

Vexim

Minimally invasive spinal implant